Current state of knowledge on medical cannabis use and risk for infections: A practical guide for clinicians

Clicks: 3
ID: 315388
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #503 of 545 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 545 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Patients and clinicians broadly support medical cannabis, but acknowledge limited understanding of products, efficacy, and safety. Here, we review cannabis products, regulatory issues, microbial contamination of cannabis, and infections linked to cannabis. In the U.S., cannabis is regulated by a patchwork of federal and state laws. Three pharmaceutical-grade cannabinoids are U.S. FDA-approved, and non-FDA-approved medical cannabis products are legal in 40 states. There are no uniform standards for testing products for microbes or validated safety thresholds from state-to-state. Reports of cannabis-associated fungal and bacterial infections have been published. However, only a single case report used genome sequencing to conclusively link a disease-causing fungus (Cryptococcus neoformans) to cannabis consumed by the patient. Therefore, infections can clearly complicate cannabis use, but extent of risk and specific risk factors are unknown. There is urgent need for harmonized cannabis regulation, standardized product testing and safety criteria, and clinical and translational research on infectious risks.
Reference Key
openalex_W7162847625 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kailey Hughes Kramer, Will Garner, Cornelius J. Clancy, M Hong Nguyen
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag343
URL
https://doi.org/10.1093/cid/ciag343
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.